Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes

Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes: A Pilot Study

The study team want to see if changes in lifestyle and behaviors and self-monitoring of diet and physical activity in older adults who have type 2 Diabetes (T2D) may help to prevent or reduce frailty. Frailty occurs in older adults and leads people to have falls, become disabled, require nursing home placement, and have increased risk of death. T2D is one of the major risk factors for frailty. T2D is a significant problem in older adults and is known to increase the risk of future frailty.

Study Overview

Detailed Description

Behavioral lifestyle intervention: Participants (N=40) will be randomized to the mHealth+ group Intervention group (Group A; n=20)and mHealth+ individual intervention group (Group B; n=20) group using a randomization table. (1) The mHealth+ group Intervention group (Group A) will receive a modified Look AHEAD behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity. This comprises ten group sessions for lifestyle intervention in 6-months. The group will receive three weekly classes in the first month and then bi-weekly classes for month 2-3, and three monthly session in month four, five, and six. The frequency and layout of these classes will allow participants to master new skills gradually, then eventually wean off, and adopt the modified lifestyle as the part of their daily lives. (2) The mHealth+ individual intervention group (Group B) will receive an abbreviated behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity in one face-to-face individual session at the beginning of the study. In addition, participants will receive self-study materials, from Look Ahead modules, and a monthly follow-up phone calls for the duration of the study (6-months). The goal for these follow up phone calls are to assess understanding of the modules, to promote continued engagement with the study material, and to provide clarification on materials as needed. Participants in the mHealth+ group Intervention group (Group A) and mHealth+ individual intervention group (Group B will receive instruction on how to download an app to help them record their diet and physical activity at the beginning of the study.

Fitbit offers a simple, easy-to-use tool for tracking food and physical activity. It helps set daily calorie budget, and set and work towards goals for nutrient intake, weight loss, exercise, and more. https://www.fitbit.com/inspire 04.12.20: Due to SARS-CoV2 (COVID-19) and social distancing order, the study team are adding hemoglobin Hba1c home test.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • San Antonio, Texas, United States, 78229
        • The University of Texas Health Science Center at San Antonio

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Community-dwelling
  • Age 65 and older
  • Men and women of all ethnic groups
  • Self-reported of provider-diagnosed with Type 2 Diabetes (T2D) for at-least 6 months.
  • Received basic diabetes self-management education
  • Stable medication regimen and no medication changes are expected over the next 6 months.
  • Overweight/obese (Body Mass Index (BMI) ≥25 kg/m2
  • Able to read and write in English
  • Own a smartphone
  • At PI discretion, participant is willing/able to comply with the protocol requirements

Exclusion Criteria:

  • Unsafe to walk using Exercise Assessment and Screening for You (EASY) criteria or clinical judgement of the PI.
  • History of severe psychiatric disorders or cognitive impairment which interferes with active participation in the study
  • Residence of long-term care facility
  • History of substance abuse in the past year
  • Unwilling to be randomized in a Mobile Health (mHealth+) individual intervention group

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Lifestyle Intervention
The participants will receive behavioral lifestyle intervention with a smartphone-based self-monitoring for diet and physical activity. This group also includes a total of 10 Group sessions over 6 months.
A mobile app used to assist with lifestyle changes
A modified Look AHEAD behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity
Other: Group B control arm
Participants use the smart-phone app to record their daily diet and physical activity, with no group sessions.
A mobile app used to assist with lifestyle changes
An abbreviated Look AHEAD behavior lifestyle intervention with smartphone-based self-monitoring of diet and physical activity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frailty Scale Using Fried's Phenotype Method Based on Five Frailty Characteristics
Time Frame: Baseline to 6 months
  1. Self-reported (SR) exhaustion (Y/N ) on Center for Epidemiologic Studies Depression (CES-D) scale: "Do you feel full of energy?" "No" scored a 1 (exhausted).
  2. SR unintentional weight loss: "In the last year, have you lost more than 10 pounds unintentionally?". "Yes" scored a 1.
  3. SR physical activity over the last year using the Minnesota Leisure Time Activity Questionnaire, (energy expenditure in kcal/week, standardized for sex). The lowest quintile for each sex group received a score of 1
  4. Grip strength measured (Kg) with a dynamometer in the dominant hand, standardized using body mass index quartiles and sex. The average of 3 trials was recorded. The lowest quintile for each sex group received a score of 1 (for weak).
  5. 10 feet walked at usual pace, standardized based on height and sex. The fastest of 2 trials was recorded. Participants in the lowest quintile for each sex group were considered slow (score =1) A higher scale score from 0-5 indicates greater frailty
Baseline to 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glycated Hemoglobin (HbA1c)
Time Frame: Baseline to 6 months
Change in HbA1c measured over the study period
Baseline to 6 months
Short Physical Performance Battery (SPPB) Balance
Time Frame: Baseline to 6 months

The balance test assesses a person's ability to stand with the feet together in side-by-side, semi-tandem, and full-tandem positions for 10 seconds each, responses ranging between 0-4 with a higher score indicating better balance. Three balance tests are performed and scoring is as follows:

Side-by-side stand: person attempts to stand with feet together, side-by-side, for 10 seconds.

  • 1 point if held for 10 seconds
  • 0 points if not held for 10 seconds or not attempted Semi-tandem stand: person attempts to stand with the side of the heel of one foot touching the big toe of the other foot for 10 seconds.
  • 1 point if held for 10 seconds
  • 0 points if not held for 10 seconds or not attempted Tandem stand: person attempts to stand with the heel of one foot in front of and touching the toes of the other foot for about 10 seconds.
  • 2 points if held for 10 seconds
  • 1 point if held for 3 to 9.99 seconds
  • 0 points if held for <3 seconds or not attempted
Baseline to 6 months
SPPB Gait Speed
Time Frame: Baseline to 6 months

Gait speed at a 4-meter walk is timed in seconds as participants walk at their usual pace. Two trials were administered, time (in seconds) was recorded for each trial. The fastest walk of two trials was recorded. Score is recorded between 0-4 with a higher score indicating a faster gait speed. Scoring is as follows:

  • 0 points if unable to do the walk
  • 1 point if time is more than 8.70 sec
  • 2 points if time is 6.21 to 8.70 sec
  • 3 points if time is 4.82 to 6.20 sec
  • 4 points if time is less than 4.82 sec
Baseline to 6 months
SPPB Chair Stands
Time Frame: Baseline to 6 months

Chair stand represents the time to complete five chair rises, sit to stand from a chair, as quickly as possible, without using hands, responses ranging between 0-4. Scoring is as follows:

  • 0 points if unable to complete 5 chair stands or completes stands in >60 seconds
  • 1 point if chair stand time is 16.70 sec or more
  • 2 points if chair stand time is 13.70 to 16.69 sec or more
  • 3 points if chair stand time is 11.20 to 13.69 sec
  • 4 points if chair stand time is 11.19 sec or less
Baseline to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rozmin Jiwani, RN, PhD, University of Texas Health at San Antonio

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2019

Primary Completion (Actual)

October 20, 2020

Study Completion (Actual)

April 28, 2022

Study Registration Dates

First Submitted

June 17, 2020

First Submitted That Met QC Criteria

June 17, 2020

First Posted (Actual)

June 19, 2020

Study Record Updates

Last Update Posted (Actual)

May 24, 2022

Last Update Submitted That Met QC Criteria

May 3, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • HSC20190019H
  • P30AG044271 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Information will be shared with mentors and advisors

IPD Sharing Time Frame

Data will be available at study completion

IPD Sharing Access Criteria

Study Teams plans on publication at completion of data analysis.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Lifestyle App

3
Subscribe